menu search

Tg therapeutics to participate in the 5th annual guggenheim inflammation, neurology & immunology (ini) conference

Fireside chat scheduled for Monday, November 6, 2023, at 3:10 PM ET NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) ...

November 3, 2023, 11:30 am

Astria therapeutics to present new star-0215 data at the 2023 american college of allergy, asthma, and immunology annual scientific meeting

BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allerg...

November 3, 2023, 8:10 am

Dbv technologies to present new data at acaai 2023

Montrouge, France, November 2, 2023 DBV Technologies to Present New Data at ACAAI 2023 New data to include late-breaking abstract detailing interim 12...

November 2, 2023, 4:30 pm

Kalvista pharmaceuticals to present data at the 2023 annual scientific meeting of the american college of allergy, asthma & immunology

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...

November 2, 2023, 6:30 am

Hillevax to present at upcoming investor conferences

BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commerci...

November 1, 2023, 4:48 pm

Anaptys announces participation in november investor conferences

SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative ...

November 1, 2023, 9:15 am

Outlook therapeutics® to present at guggenheim's 5th annual inflammation, neurology & immunology (ini) conference

Live audio webcast fireside chat on Tuesday, November 7th at 1:50 PM ET Live audio webcast fireside chat on Tuesday, November 7th at 1:50 PM ET...

November 1, 2023, 8:05 am

Astrazeneca inks gene editing deal that could end up costing it $2.5bn

AstraZeneca PLC (LSE:AZN) has entered into a partnership and investment deal with French gene editing specialist biotech firm Cellectis (NASDAQ:CLLS) ...

November 1, 2023, 3:59 am

Argenx to present at upcoming investor conferences

November 1, 2023 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology c...

November 1, 2023, 2:00 am

Why abbvie stock fell today

AbbVie stock fell today despite easily exceeding estimates for its third quarter. Revenue declines across AbbVie's ...

October 27, 2023, 3:06 pm

Argenx to report third quarter 2023 financial results and business update on october 31, 2023

October 24, 2023 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology c...

October 24, 2023, 1:00 am

Roivant, pfizer shares rise as roche agrees to buy immunology company for $7.1 billion

Shares of Roivant Sciences Ltd. ROIV, -1.13% and Pfizer Inc. PFE, -1.73% gained ground premarket on Monday after Roche Holding AG RHHBY, +0.51% agreed...

October 23, 2023, 8:36 am

Roche agrees $7.1 billion for drug company

It will buy immunology company Telavant Holdings from Roivant Sciences and Pfizer....

October 23, 2023, 5:40 am

Volitionrx highlights study demonstrating nu.q nets is promising biomarker for septic shock

VolitionRx (NYSE-A:VNRX) has highlighted a recently published paper in Annals of Intensive Care which shows the company's Nu.Q NETs test is a promisin...

October 19, 2023, 9:32 am

: sanofi reaps rewards of immunology investment with eczema results

Pharmaceutical giant set to take on Amgen with atopic dermatitis treatment. Read Full Story The post : Sanofi reaps rewards of ...

October 13, 2023, 2:00 pm

Pharvaris to present at the apaaaci 2023 international conference

ZUG, Switzerland, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2 receptor a...

October 13, 2023, 6:50 am

Anaptys to present phase 1 data on anb032, its btla agonist antibody, at the 32nd eadv congress

SAN DIEGO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative ...

October 11, 2023, 9:15 am

Gsk reportedly set to shake up r&d opertion

GSK PLC (LSE:GSK, NYSE:GSK) is set to restructure its research division, impacting scientists in the UK, the US, and Belgium, according to the Sunday ...

October 9, 2023, 2:14 am

Gri bio announces publication of comprehensive invariant nkt (inkt) cell review in frontiers in immunology demonstrating a key role of type 1 inkt cells in modulating various fibrotic conditions

In several murine models of chronic inflammation and fibrosis, as well as in humans, it has been shown that iNKT cells are selectively activated in th...

October 5, 2023, 12:45 pm

Pharvaris to present at the ciic fall 2023 conference

ZUG, Switzerland, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor a...

October 4, 2023, 7:34 am


Search within

Pages Search Results: